Showing results (1-10 of 288) with videos related to

Sort By:
Pageof 29
Frontiers in Bioscience (Elite Edition)|June 2, 2009
Toll-like receptors, innate immunity and lung transplantationLaurie D Snyder, Scott M Palmer
Seminars in Respiratory and Critical Care Medicine|October 31, 2006
Immune mechanisms of lung allograft rejectionLaurie D Snyder, Scott M Palmer
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 20, 2018
Pre-transplant weight loss and clinical outcomes after lung transplantationEmily Siu Clausen, Courtney Frankel, Scott M Palmer, et al.
Clinical Transplantation|January 28, 2018
Complement system in lung transplantationHakim Azfar Ali, Elizabeth N Pavlisko, Laurie D Snyder, et al.
Chest|November 20, 2008
Diagnosis and outcome of early pleural space infection following lung transplantationMomen M Wahidi, Daniel A Willner, Laurie D Snyder, et al.
American Journal of Respiratory and Critical Care Medicine|February 20, 2010
Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantationLaurie D Snyder, C Ashley Finlen-Copeland, W Jackson Turbyfill, et al.
Clinical Transplants|July 22, 2008
Lung transplantation at Duke University Medical CenterLaurie D Snyder, Ashley Finlen-Copeland, Matthew G Hartwig, et al.
American Journal of Respiratory Cell and Molecular Biology|October 1, 2011
Protective role of T-bet and Th1 cytokines in pulmonary graft-versus-host disease and peribronchiolar fibrosisKymberly M Gowdy, Julia L Nugent, Tereza Martinu, et al.
American Journal of Respiratory and Critical Care Medicine|May 29, 2010
Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipientsC Ashley Finlen Copeland, Laurie D Snyder, David W Zaas, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 15, 2011
Long-term efficacy and safety of 12 months of valganciclovir prophylaxis compared with 3 months after lung transplantation: a single-center, long-term follow-up analysis from a randomized, controlled cytomegalovirus prevention trialC Ashley Finlen Copeland, W Austin Davis, Laurie D Snyder, et al.
Pageof 29